<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>eXoZymes</itunes:name>
            <itunes:email>lasse.g@exozymes.com</itunes:email>
        </itunes:owner>
        <title>Heltzen's updates</title>
        <link>https://exozymes.twentythree.com</link>
        <description>CEO of eXoZymes, Michael Heltzen, shares his thoughts on various topics.</description>
        <language>en-us</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>eXoZymes</itunes:author>
        <itunes:summary>CEO of eXoZymes, Michael Heltzen, shares his thoughts on various topics.</itunes:summary>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://exozymes.twentythree.com/files/rv0.0/sitelogo.gif"/>
        <image>
            <url>https://exozymes.twentythree.com/files/rv0.0/sitelogo.gif</url>
            <title>Heltzen's updates</title>
            <link>https://exozymes.twentythree.com</link>
        </image>
        <atom:link rel="self" href="https://exozymes.twentythree.com/audiopodcast/heltzens-updates"/>
        <atom:link rel="next" href="https://exozymes.twentythree.com/audiopodcast/heltzens-updates?p=2&amp;album%5fid=110131138&amp;podcast%5fp=t&amp;https="/>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968569/123105472/5432476e35196bee968a40f5ed725616/audio/podcast/123105472-18-audio.mp3" type="audio/mp3" length="9764395"/>
            <title>Nasdaq: Michael B. Spector interviews CEO Heltzen</title>
            <link>http://exozymes.twentythree.com/nasdaq-michael-b-spector-interviews</link>
            <description>&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/nasdaq-michael-b-spector-interviews"&gt;&lt;img src="http://exozymes.twentythree.com/64968569/123105472/5432476e35196bee968a40f5ed725616/standard/download-18-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/123105472</guid>
            <pubDate>Wed, 18 Mar 2026 22:18:54 GMT</pubDate>
            <media:title>Nasdaq: Michael B. Spector interviews CEO Heltzen</media:title>
            <itunes:summary></itunes:summary>
            <itunes:subtitle></itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>13:34</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/nasdaq-michael-b-spector-interviews"&gt;&lt;img src="http://exozymes.twentythree.com/64968569/123105472/5432476e35196bee968a40f5ed725616/standard/download-18-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=5432476e35196bee968a40f5ed725616&amp;source=podcast&amp;photo%5fid=123105472" width="625" height="352" type="text/html" medium="video" duration="814" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968569/123105472/5432476e35196bee968a40f5ed725616/standard/download-18-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968569/123105472/5432476e35196bee968a40f5ed725616/standard/download-18-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968571/123744939/5b1f0ce6888e96bb78dda82d2211cc54/audio/podcast/123744939-12-audio.mp3" type="audio/mp3" length="1081610"/>
            <title>Nasdaq HERO</title>
            <link>http://exozymes.twentythree.com/nasdaq-hero</link>
            <description>&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/nasdaq-hero"&gt;&lt;img src="http://exozymes.twentythree.com/64968571/123744939/5b1f0ce6888e96bb78dda82d2211cc54/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/123744939</guid>
            <pubDate>Wed, 18 Feb 2026 23:33:44 GMT</pubDate>
            <media:title>Nasdaq HERO</media:title>
            <itunes:summary></itunes:summary>
            <itunes:subtitle></itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>01:30</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/nasdaq-hero"&gt;&lt;img src="http://exozymes.twentythree.com/64968571/123744939/5b1f0ce6888e96bb78dda82d2211cc54/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=5b1f0ce6888e96bb78dda82d2211cc54&amp;source=podcast&amp;photo%5fid=123744939" width="625" height="352" type="text/html" medium="video" duration="90" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968571/123744939/5b1f0ce6888e96bb78dda82d2211cc54/standard/download-12-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968571/123744939/5b1f0ce6888e96bb78dda82d2211cc54/standard/download-12-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968561/120191657/81412a44701bd80b4e8b55c7eb00d485/audio/podcast/120191657-35-audio.mp3" type="audio/mp3" length="37341868"/>
            <title>Heltzen's Highlights: 2025 in Review and Looking Ahead</title>
            <link>http://exozymes.twentythree.com/heltzens-highlights-2025-in-review</link>
            <description>&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/heltzens-highlights-2025-in-review"&gt;&lt;img src="http://exozymes.twentythree.com/64968561/120191657/81412a44701bd80b4e8b55c7eb00d485/standard/download-35-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/120191657</guid>
            <pubDate>Fri, 02 Jan 2026 22:05:15 GMT</pubDate>
            <media:title>Heltzen's Highlights: 2025 in Review and Looking Ahead</media:title>
            <itunes:summary></itunes:summary>
            <itunes:subtitle></itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>51:52</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/heltzens-highlights-2025-in-review"&gt;&lt;img src="http://exozymes.twentythree.com/64968561/120191657/81412a44701bd80b4e8b55c7eb00d485/standard/download-35-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=81412a44701bd80b4e8b55c7eb00d485&amp;source=podcast&amp;photo%5fid=120191657" width="625" height="352" type="text/html" medium="video" duration="3112" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968561/120191657/81412a44701bd80b4e8b55c7eb00d485/standard/download-35-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968561/120191657/81412a44701bd80b4e8b55c7eb00d485/standard/download-35-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968568/118436186/a5af6e07da9e042b4ec51bbf11064afd/audio/podcast/118436186-141-audio.mp3" type="audio/mp3" length="22906599"/>
            <title>'The Upside' interview: Michael Heltzen &amp; Lou Basenese</title>
            <link>http://exozymes.twentythree.com/the-upside-interview-michael</link>
            <description>&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/the-upside-interview-michael"&gt;&lt;img src="http://exozymes.twentythree.com/64968568/118436186/a5af6e07da9e042b4ec51bbf11064afd/standard/download-141-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/118436186</guid>
            <pubDate>Tue, 18 Nov 2025 18:40:31 GMT</pubDate>
            <media:title>'The Upside' interview: Michael Heltzen &amp; Lou Basenese</media:title>
            <itunes:summary></itunes:summary>
            <itunes:subtitle></itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>31:49</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/the-upside-interview-michael"&gt;&lt;img src="http://exozymes.twentythree.com/64968568/118436186/a5af6e07da9e042b4ec51bbf11064afd/standard/download-141-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=a5af6e07da9e042b4ec51bbf11064afd&amp;source=podcast&amp;photo%5fid=118436186" width="625" height="350" type="text/html" medium="video" duration="1909" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968568/118436186/a5af6e07da9e042b4ec51bbf11064afd/standard/download-141-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968568/118436186/a5af6e07da9e042b4ec51bbf11064afd/standard/download-141-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968575/117485298/de8a8c4306780d5e93a151f4c0f4d126/audio/podcast/117485298-29-audio.mp3" type="audio/mp3" length="30151827"/>
            <title>The Catalyst Podcast: Interview with CEO Michael Heltzen</title>
            <link>http://exozymes.twentythree.com/the-catalyst-podcast-interview-with</link>
            <description>&lt;p&gt;&lt;p&gt;The Catalyst Podcast by&amp;nbsp;Igor Rafalovich is available here:&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/@TheHealthcareCatalyst"&gt;https://www.youtube.com/@TheHealthcareCatalyst&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/the-catalyst-podcast-interview-with"&gt;&lt;img src="http://exozymes.twentythree.com/64968575/117485298/de8a8c4306780d5e93a151f4c0f4d126/standard/download-29-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/117485298</guid>
            <pubDate>Tue, 11 Nov 2025 18:33:33 GMT</pubDate>
            <media:title>The Catalyst Podcast: Interview with CEO Michael Heltzen</media:title>
            <itunes:summary>The Catalyst Podcast byIgor Rafalovich is available here:https://www.youtube.com/@TheHealthcareCatalyst</itunes:summary>
            <itunes:subtitle>The Catalyst Podcast byIgor Rafalovich is available here:https://www.youtube.com/@TheHealthcareCatalyst</itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>41:53</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;The Catalyst Podcast by&amp;nbsp;Igor Rafalovich is available here:&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/@TheHealthcareCatalyst"&gt;https://www.youtube.com/@TheHealthcareCatalyst&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/the-catalyst-podcast-interview-with"&gt;&lt;img src="http://exozymes.twentythree.com/64968575/117485298/de8a8c4306780d5e93a151f4c0f4d126/standard/download-29-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=de8a8c4306780d5e93a151f4c0f4d126&amp;source=podcast&amp;photo%5fid=117485298" width="625" height="327" type="text/html" medium="video" duration="2513" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968575/117485298/de8a8c4306780d5e93a151f4c0f4d126/standard/download-29-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968575/117485298/de8a8c4306780d5e93a151f4c0f4d126/standard/download-29-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968556/118257287/2c286b6959c9ec4d94014237597b2c59/audio/podcast/118257287-14-audio.mp3" type="audio/mp3" length="2070606"/>
            <title>Heltzen's Video Highlight: November 2025</title>
            <link>http://exozymes.twentythree.com/heltzens-video-highlight-november</link>
            <description>&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/heltzens-video-highlight-november"&gt;&lt;img src="http://exozymes.twentythree.com/64968556/118257287/2c286b6959c9ec4d94014237597b2c59/standard/download-14-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/118257287</guid>
            <pubDate>Mon, 10 Nov 2025 23:38:19 GMT</pubDate>
            <media:title>Heltzen's Video Highlight: November 2025</media:title>
            <itunes:summary></itunes:summary>
            <itunes:subtitle></itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>02:52</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/heltzens-video-highlight-november"&gt;&lt;img src="http://exozymes.twentythree.com/64968556/118257287/2c286b6959c9ec4d94014237597b2c59/standard/download-14-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=2c286b6959c9ec4d94014237597b2c59&amp;source=podcast&amp;photo%5fid=118257287" width="625" height="352" type="text/html" medium="video" duration="172" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968556/118257287/2c286b6959c9ec4d94014237597b2c59/standard/download-14-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968556/118257287/2c286b6959c9ec4d94014237597b2c59/standard/download-14-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968566/116809652/57bf182bbf94a8725d8cd036bcc805ba/audio/podcast/116809652-15-audio.mp3" type="audio/mp3" length="4271788"/>
            <title>Heltzen's Video Highlight: September 2025</title>
            <link>http://exozymes.twentythree.com/heltzens-video-highlight-september</link>
            <description>&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/heltzens-video-highlight-september"&gt;&lt;img src="http://exozymes.twentythree.com/64968566/116809652/57bf182bbf94a8725d8cd036bcc805ba/standard/download-15-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/116809652</guid>
            <pubDate>Fri, 26 Sep 2025 01:01:22 GMT</pubDate>
            <media:title>Heltzen's Video Highlight: September 2025</media:title>
            <itunes:summary></itunes:summary>
            <itunes:subtitle></itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>05:56</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/heltzens-video-highlight-september"&gt;&lt;img src="http://exozymes.twentythree.com/64968566/116809652/57bf182bbf94a8725d8cd036bcc805ba/standard/download-15-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=57bf182bbf94a8725d8cd036bcc805ba&amp;source=podcast&amp;photo%5fid=116809652" width="625" height="352" type="text/html" medium="video" duration="356" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968566/116809652/57bf182bbf94a8725d8cd036bcc805ba/standard/download-15-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968566/116809652/57bf182bbf94a8725d8cd036bcc805ba/standard/download-15-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968566/115936637/2356537ebbf18074b07b2013e165da45/audio/podcast/115936637-12-audio.mp3" type="audio/mp3" length="700431"/>
            <title>Thank you, MDB Capital</title>
            <link>http://exozymes.twentythree.com/thank-you-mdb-capital</link>
            <description>&lt;p&gt;&lt;p&gt;A big shoutout to MDB Capital for last week’s investor conference in Dallas, Texas!&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/thank-you-mdb-capital"&gt;&lt;img src="http://exozymes.twentythree.com/64968566/115936637/2356537ebbf18074b07b2013e165da45/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/115936637</guid>
            <pubDate>Mon, 08 Sep 2025 13:45:26 GMT</pubDate>
            <media:title>Thank you, MDB Capital</media:title>
            <itunes:summary>A big shoutout to MDB Capital for last week’s investor conference in Dallas, Texas!</itunes:summary>
            <itunes:subtitle>A big shoutout to MDB Capital for last week’s investor conference in Dallas, Texas!</itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>00:58</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;A big shoutout to MDB Capital for last week’s investor conference in Dallas, Texas!&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/thank-you-mdb-capital"&gt;&lt;img src="http://exozymes.twentythree.com/64968566/115936637/2356537ebbf18074b07b2013e165da45/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=2356537ebbf18074b07b2013e165da45&amp;source=podcast&amp;photo%5fid=115936637" width="625" height="352" type="text/html" medium="video" duration="58" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968566/115936637/2356537ebbf18074b07b2013e165da45/standard/download-12-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968566/115936637/2356537ebbf18074b07b2013e165da45/standard/download-12-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968566/112494247/28303e73629499850f46ead82a50ec4d/audio/podcast/112494247-12-audio.mp3" type="audio/mp3" length="48661254"/>
            <title>Slack Capital interview: Michael Heltzen, CEO</title>
            <link>http://exozymes.twentythree.com/slack-capital-interview-michael</link>
            <description>&lt;p&gt;&lt;p&gt;Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. &lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;The full interview and link to download the report is available here:&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" rel="noopener noreferrer nofollow" href="https://exozymes.com/blog/slack-capital-ceo"&gt;https://exozymes.com/blog/slack-capital-ceo&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport &lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/slack-capital-interview-michael"&gt;&lt;img src="http://exozymes.twentythree.com/64968566/112494247/28303e73629499850f46ead82a50ec4d/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/112494247</guid>
            <pubDate>Tue, 13 May 2025 16:36:46 GMT</pubDate>
            <media:title>Slack Capital interview: Michael Heltzen, CEO</media:title>
            <itunes:summary>Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. The full interview and link to download the report is available here:https://exozymes.com/blog/slack-capital-ceo#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport </itunes:summary>
            <itunes:subtitle>Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. The full interview and link to...</itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>01:07:35</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. &lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;The full interview and link to download the report is available here:&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" rel="noopener noreferrer nofollow" href="https://exozymes.com/blog/slack-capital-ceo"&gt;https://exozymes.com/blog/slack-capital-ceo&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport &lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/slack-capital-interview-michael"&gt;&lt;img src="http://exozymes.twentythree.com/64968566/112494247/28303e73629499850f46ead82a50ec4d/standard/download-12-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=28303e73629499850f46ead82a50ec4d&amp;source=podcast&amp;photo%5fid=112494247" width="625" height="352" type="text/html" medium="video" duration="4055" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968566/112494247/28303e73629499850f46ead82a50ec4d/standard/download-12-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968566/112494247/28303e73629499850f46ead82a50ec4d/standard/download-12-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968579/112735956/ef34239d7f0662f4f1444286418786b4/audio/podcast/112735956-13-audio.mp3" type="audio/mp3" length="424899"/>
            <title>Slack Capital interview: Michael Heltzen, CEO (teaser)</title>
            <link>http://exozymes.twentythree.com/slack-capital-interview-michael-1</link>
            <description>&lt;p&gt;&lt;p&gt;Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. &lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;The full interview and link to download the report is available here:&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" rel="noopener noreferrer nofollow" href="https://exozymes.com/blog/slack-capital-ceo"&gt;https://exozymes.com/blog/slack-capital-ceo&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport &lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/slack-capital-interview-michael-1"&gt;&lt;img src="http://exozymes.twentythree.com/64968579/112735956/ef34239d7f0662f4f1444286418786b4/standard/download-13-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/112735956</guid>
            <pubDate>Tue, 13 May 2025 16:34:43 GMT</pubDate>
            <media:title>Slack Capital interview: Michael Heltzen, CEO (teaser)</media:title>
            <itunes:summary>Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. The full interview and link to download the report is available here:https://exozymes.com/blog/slack-capital-ceo#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport </itunes:summary>
            <itunes:subtitle>Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. The full interview and link to...</itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>00:35</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;Today, Slack Capital - an Australian investment research publication - has released an investment report on eXoZymes. The release of the report is accompanied by an hour-long interview with our CEO, Michael Heltzen. &lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;The full interview and link to download the report is available here:&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" rel="noopener noreferrer nofollow" href="https://exozymes.com/blog/slack-capital-ceo"&gt;https://exozymes.com/blog/slack-capital-ceo&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;#AI #biomanufacturing #nutraceuticals #enzymes #exozymes #investmentreport &lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/slack-capital-interview-michael-1"&gt;&lt;img src="http://exozymes.twentythree.com/64968579/112735956/ef34239d7f0662f4f1444286418786b4/standard/download-13-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=ef34239d7f0662f4f1444286418786b4&amp;source=podcast&amp;photo%5fid=112735956" width="625" height="352" type="text/html" medium="video" duration="35" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968579/112735956/ef34239d7f0662f4f1444286418786b4/standard/download-13-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968579/112735956/ef34239d7f0662f4f1444286418786b4/standard/download-13-thumbnail.jpg/thumbnail.jpg"/>
        </item>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968579/110130321/70d0c03522bf55b6e13e6d9bf8bdac17/audio/podcast/110130321-18-audio.mp3" type="audio/mp3" length="1375018"/>
            <title>Nasdaq: eXoZymes CEO Michael Heltzen's closing bell speech</title>
            <link>http://exozymes.twentythree.com/nasdaq-exozymes-ceo-michael</link>
            <description>&lt;p&gt;&lt;p&gt;This  Michael Heltzen's (CEO of eXoZymes) closing bell speech from February 19, 2025, when eXoZymes rang the closing bell at Nasdaq in New York.&lt;br&gt;&lt;/p&gt;
&lt;p&gt;CEO of eXoZymes, Michael Heltzen, states: "&lt;em&gt;I want to bring the attention to that&amp;nbsp;this is the beginning of a long journey.&amp;nbsp;It's a thing where we are going to have to have&amp;nbsp;partners and collaborators help out.&amp;nbsp;This is not a technology breakthrough&amp;nbsp;that we are going to keep to ourselves. We want to share it.&amp;nbsp;We want to share it with all of the world.&amp;nbsp;And with that,&amp;nbsp;please come join us,&amp;nbsp;help us,&amp;nbsp;support us,&amp;nbsp;at least follow us so we can have a conversation about how the future&amp;nbsp;can be a more sustainable future while still having the good life.&lt;/em&gt;"&lt;/p&gt;
&lt;p&gt;&lt;br&gt;Credit: Nasdaq, Inc.&lt;/p&gt;
&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/nasdaq-exozymes-ceo-michael"&gt;&lt;img src="http://exozymes.twentythree.com/64968579/110130321/70d0c03522bf55b6e13e6d9bf8bdac17/standard/download-18-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/110130321</guid>
            <pubDate>Thu, 20 Feb 2025 17:42:07 GMT</pubDate>
            <media:title>Nasdaq: eXoZymes CEO Michael Heltzen's closing bell speech</media:title>
            <itunes:summary>This  Michael Heltzen's (CEO of eXoZymes) closing bell speech from February 19, 2025, when eXoZymes rang the closing bell at Nasdaq in New York.
CEO of eXoZymes, Michael Heltzen, states: "I want to bring the attention to thatthis is the beginning of a long journey.It's a thing where we are going to have to havepartners and collaborators help out.This is not a technology breakthroughthat we are going to keep to ourselves. We want to share it.We want to share it with all of the world.And with that,please come join us,help us,support us,at least follow us so we can have a conversation about how the futurecan be a more sustainable future while still having the good life."
Credit: Nasdaq, Inc.
</itunes:summary>
            <itunes:subtitle>This  Michael Heltzen's (CEO of eXoZymes) closing bell speech from February 19, 2025, when eXoZymes rang the closing bell at Nasdaq in New York.
CEO of eXoZymes, Michael Heltzen, states: "I want to bring the attention to thatthis is the beginning...</itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>01:55</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;This  Michael Heltzen's (CEO of eXoZymes) closing bell speech from February 19, 2025, when eXoZymes rang the closing bell at Nasdaq in New York.&lt;br&gt;&lt;/p&gt;
&lt;p&gt;CEO of eXoZymes, Michael Heltzen, states: "&lt;em&gt;I want to bring the attention to that&amp;nbsp;this is the beginning of a long journey.&amp;nbsp;It's a thing where we are going to have to have&amp;nbsp;partners and collaborators help out.&amp;nbsp;This is not a technology breakthrough&amp;nbsp;that we are going to keep to ourselves. We want to share it.&amp;nbsp;We want to share it with all of the world.&amp;nbsp;And with that,&amp;nbsp;please come join us,&amp;nbsp;help us,&amp;nbsp;support us,&amp;nbsp;at least follow us so we can have a conversation about how the future&amp;nbsp;can be a more sustainable future while still having the good life.&lt;/em&gt;"&lt;/p&gt;
&lt;p&gt;&lt;br&gt;Credit: Nasdaq, Inc.&lt;/p&gt;
&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/nasdaq-exozymes-ceo-michael"&gt;&lt;img src="http://exozymes.twentythree.com/64968579/110130321/70d0c03522bf55b6e13e6d9bf8bdac17/standard/download-18-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=70d0c03522bf55b6e13e6d9bf8bdac17&amp;source=podcast&amp;photo%5fid=110130321" width="625" height="352" type="text/html" medium="video" duration="115" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968579/110130321/70d0c03522bf55b6e13e6d9bf8bdac17/standard/download-18-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968579/110130321/70d0c03522bf55b6e13e6d9bf8bdac17/standard/download-18-thumbnail.jpg/thumbnail.jpg"/>
        </item>
    </channel>
</rss>
